Hairy Cell Leukemia (HCL)
Also known as: Hairy Cell Leukemia / Leukemia, Hairy Cell / Hairy cell leukaemia / Hairy-cell Leukemia / HCL / Hairy cell leukemia not having achieved remission / Hairy cell leukemia (disorder) / Hairy cell leukemia (morphologic abnormality) / Leukemic reticuloendotheliosis / Leukaemic reticuloendotheliosis
Drug | Drug Name | Drug Description |
---|---|---|
DB00242 | Cladribine | A purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs. |
DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |
DB00105 | Interferon alfa-2b | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. |
DB12688 | Moxetumomab pasudotox | A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. |
DB00552 | Pentostatin | An adenosine deaminase inhibitor used to treat hairy cell leukemia. |